TGFB1 and renal fibrosis: Of these, patients with type 2 diabetes have been reported with higher expression of TGF-β1, a key profibrotic cytokine which accelerates the progression of renal fibrosis [53], glomerular mesangial hypertrophy [54], excessive amassing of extracellular matrix (ECM) [55].